FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access
May 03, 2026
View online
FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access
OncoBillionaires 2026: 28 Billionaires Powering Innovation and Access Challenges
Gedatolisib in VIKTORIA-1: Positive Topline Data in PIK3CA-Mutant Metastatic Breast Cancer
Join Us At SIOP Europe Congress 2026 For An Insightful Session On Pediatric ALL
Charles Swanton: How Does Lung Cancer Actually Spread?
Cancer Cannot Wait as Europe Risks Turning Away from Health Funding
Muna Al-Khaifi: Early Survivorship Integration and Patient-Centered Cancer Care
Top Phase 3 Immunotherapy Trials at ASCO 2026
Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)
Horizon Europe Cancer Mission — Pragmatic Clinical Trials for Immunotherapy in Refractory Cancers (HORIZON-MISS-2026-02-CANCER-03)
Scalp Cooling for Prevention of Hair Loss in Pediatric ALL – Resonance
NCCN 2026 Policy Summit: Health Literacy in the Cancer Care Digital Age
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
